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Introduction
First trimester nuchal translucency (NT) measurement is an established method of screening for fetal chromosomal abnormalities 1, 2, 3 . It has also been suggested that increased NT is associated with increased risk of fetal loss 4 − 13 . Because NT measurement at 12 − 14 weeks is now routinely offered at many centres, it is of interest to be able to estimate the risk of subsequent miscarriage and convey information on prognosis after having demonstrated an apparently normal fetus at the NT scan.
The primary aim of this study was to estimate the risk of second trimester miscarriage in women with a low risk of carrying a fetus with a chromosomal abnormality according to NT screening. A secondary aim was to determine if NT thickness or other factors affect the risk of subsequent miscarriage in these women.
Subjects and methods
Our study population is a subgroup of pregnant women derived from the '12-week arm' of the Swedish NUPP-trial (NUPP is an abbreviation for NackUPPklarning, which is Swedish for nuchal translucency). This national multi-centre trial has been described in detail in several publications 14 − 16 . Pregnant women who consented to take part in the trial were randomized to a single routine ultrasound examination either at 12 -14 gestational weeks or at 18 -20 weeks. Our study group comprises 14 278 pregnancies fulfilling the following criteria: singleton pregnancy with an apparently normal fetus at the 12-week routine scan, estimated risk of trisomy 21 < 1:250 with risk estimated on the basis of maternal age, fetal crown-rump length (CRL) and NT (but not biochemistry, e.g., PAPP-A or beta-hCG) using the software of the Fetal Medicine Foundation, (FMF) 17 , and no amniocentesis, chorion villus sampling or cordocentesis < 25 weeks. A flow chart demonstrating the selection of our study group is shown in Figure 1 .
The 12-week scans were performed transabdominally by 46 specially trained midwives with median 11 (interquartile range, 5 − 17) years' experience of mid-trimester routine ultrasound examinations. They included measurement of CRL and biparietal diameter (BPD), scrutiny of fetal anatomy following a predefined check-list, and measurement of NT in accordance with the technical guidelines published by the FMF 17 . The risk of trisomy 21 was calculated using the FMF software with risk calculation being done without biochemistry 17 , see above. Any suspicion of fetal malformation at screening was confirmed or refuted by an obstetrician trained in obstetric ultrasound. Women with a risk of trisomy 21 ≥1:250 were offered fetal karyotyping and so were women with a history suggesting an increased risk of fetal chromosomal anomaly (e.g., a previous pregnancy where the fetus had a chromosomal anomaly), and women carrying a fetus with a structural anomaly. For more details on study design we refer the reader to previous publications 14 -16 .
To facilitate follow-up, all women were given a questionnaire at their routine scan where they were asked to report pregnancy outcome (e.g., the name of the hospital where they had given birth). Information on pregnancy outcome was retrieved from patient records, from departments of neonatology, pediatric cardiology, pediatric surgery, neurosurgery, plastic surgery, genetics and pathology providing services to the hospitals involved, from the National Registry of Congenital Anomalies, and in some cases from personal contact with the women. For all pregnancies in the study group we had full information about the outcome of pregnancy with regard to the vital status of the fetus/child and the presence/absence of congenital malformations diagnosed before the baby was dismissed from postnatal care.
For statistical purposes fetuses and newborns with more than one malformation were assigned one main malformation diagnosis. Congenital heart malformations diagnosed within the first 12 months of life, and other types of malformation diagnosed (or suspected and later confirmed) before the baby was dismissed from postnatal care were included. Malformations were grouped into four categories according to their likely clinical consequences as described before 18 : 1) lethal malformations 2) severe malformations 3) malformations of intermediate severity 4) minor malformations. Minor malformations are not accounted for in this study.
Miscarriage was defined as spontaneous fetal loss <25 weeks of pregnancy. Perinatal death was defined as intrauterine death ≥25 weeks of pregnancy, intra-partum death, or death within 7 days of birth. In Sweden, termination of pregnancy is rarely allowed >22 weeks of pregnancy.
For the purpose of this study, gestational age was determined by fetal ultrasound biometry in all cases, also in in vitro fertilization pregnancies. We used the BPD formula of Selbing Second, analyses were performed to investigate whether our study group deviated from pregnant women not included in our study with regard to the possible risk factors for miscarriage investigated. To this end we compared parity, maternal age and number of previous miscarriages between the following three groups of women: declined randomization (group 1), randomized to an NT scan but excluded from the current study (group 2), randomized to NT scan and included in the current study (group 3). The association between parity, number of previous miscarriages and age with inclusion in group 3 vs. in group 1 and 2 was explored using multivariate logistic regression analyses, where an interaction term between parity and number of previous miscarriages was also added. The same types of multiple logistic regression analyses were carried out to predict inclusion in group 3 versus in group 2. The possibility of parity affecting the estimation of risk of Down´s syndrome was evaluated by inspection of tabled data and by performing multivariate logistic regression analyses with parity and maternal age as predicting variables.
Two-tailed P-values < 0.05 were considered statistically significant.
Results
Demographic data and pregnancy outcome of the study group (14 278 women, 14 278 fetuses) and of the cases excluded after confirmation of the presence of at least one living fetus (3687 women, 3988 fetuses) are presented in Table 1 . Two hundred and sixty-six fetuses (1.9%) in the study group had a malformation of at least intermediate severity.
Main diagnoses of the malformed fetuses in our study group are presented in Table 2 .
The miscarriage rate in our study group was 0.5% (77/14278; 95% CI 0.4 − 06). In 12 (16%) cases gestational age at miscarriage was unknown, 16 (21%) miscarriages were diagnosed at 12 -15 weeks, 34 (44%) at 16 -18 weeks and 15 (19%) at 22 -24 weeks. Six of the 77 fetuses lost in miscarriage underwent both autopsy and post-abortem karyotyping.
All six were normally formed and had normal karyotype. The remaining 71 fetuses underwent neither autopsy nor karyotyping.
Miscarriage rates in relation to the putative risk factors examined are presented in Tables 3   and 4, Table 3 showing descriptive statistics (numbers and percentages) and Table 4 presenting results for the uni-variate and multivariate logistic regression analyses. The risk of miscarriage increased with each previous delivery and with each previous spontaneous abortion. The odds ratio (OR) for parity changed only marginally when adjustments were made for maternal age, number of previous miscarriages and the other possible risk factors.
Similarly, the association between number of previous miscarriages and miscarriage of the current pregnancy was independent of maternal age and parity. No interaction between parity and number of previous spontaneous abortions was found. When testing the simultaneous effect of maternal age as a linear and quadratic term, a highly significant U-shaped relationship between maternal age and risk of miscarriage was revealed. The U-shaped relationship persisted with borderline statistical significance (p = 0.050) after parity and number of previous spontaneous abortions had been added to the model including the two age terms. The relation between maternal age and miscarriage is visualized in Figure 2 . The figure shows odds ratios for miscarriage based on the ´best model´ presented in Table 4 . The results from the 'best model' were also used to create graphs (one graph for each maternal age) illustrating the risk of miscarriage by parity and number of previous miscarriages. previous spontaneous abortions parity was a risk factor for miscarriage (age-adjusted OR:
1.64; 95% CI: 1.31 − 2.05), and in this sub-set, the U-shaped relationship between miscarriage and maternal age was statistically significant (p = 0.04).
Our study group -a selected group of pregnant women at low risk of carrying a fetus with a chromosomal anomaly -deviated from pregnant women not included in our study (Table 5 ).
Compared to women 25 -29 years old, younger women (not significant), and older women were less likely to participate in the current study. Even though not statistically significant (p = 0.07), our results suggest a positive interaction between parity and the number of previous miscarriages for participation in the study, i.e., with increasing parity the likelihood of being included in the current study group increased with increasing number of previous miscarriages. In the group randomized to an NT scan, only maternal age predicted exclusion (group 2 vs. group 3, see above), those excluded being older. There was no association between parity (corrected for maternal age) and having a risk of trisomy 21 <1:250.
Discussion
To estimate the true miscarriage rate after a scan has revealed a living fetus at 12 -14 gestational weeks is extremely difficult, because non-interventional observation after the scan is necessary. If scans have a clinical purpose, for instance when screening for trisomy 21 by NT measurement, non-intervention is possible only in apparently normal pregnancies, because most women at increased risk of trisomy 21 will undergo chorion villus sampling or amniocentesis, both of which increase the risk of miscarriage 22 − 24 . Moreover, if a chromosomal anomaly or a fetal malformation is revealed many women will terminate their pregnancy. This is why we decided to study a selected but well defined group of women with an apparently normal fetus at a 12-week scan and with a low risk of trisomy 21 and to include only those who did not undergo any invasive procedure before 25 gestational weeks. It is of clinical interest to be able to convey correct information on the prognosis to such ´low-risk´ women, because they constitute the vast majority (90 -95% 15, 25 ) of pregnant women. On the other hand, our results are applicable only to populations very similar to our own study population. The composition of any similar ´low-risk´ population will be determined by the ability of ultrasound examiners to detect fetal malformations at 12 -14 gestational weeks and by individual decisions, e.g., whether or not to undergo fetal karyotyping and whether or not to terminate the pregnancy for psychosocial or other reasons.
We found the risk of miscarriage to be 0.5% (95% CI of 0.4 -0.6) after an apparently normal fetus with an estimated risk of Down´s <1:250 had been seen at a 12 -14 week NT scan. This risk is lower than that reported (0.7%) among women < 35 years old with a living fetus seen at a scan at around 16 weeks 23 . One would have expected the miscarriage rate to be lower after confirmation of viability at 16 weeks than at 12 -14 weeks. Probably, the study populations differed between the two studies. It is not meaningful to compare the miscarriage rate in our study with that reported after a living fetus had been seen at a 12 -14 week scan in other published studies 4 -13 , because the other studies included only fetuses with increased NT 4, 6-8, 10, 12, 13 , only high risk pregnancies where all women underwent fetal karyotyping 5, 9 , or also fetuses with major malformations 5, 11 . As a result of this, miscarriage rates were much higher (0.9% -13.2%) in these studies than in ours.
Even though it was not the aim of our study, it may be interesting to try to estimate the miscarriage rate in a total pregnant population -as opposed to in a selected population -from our data. To do this we need to study the outcome both of the pregnancies included in our study and those excluded. Among the pregnancies for which we know the outcome (n = 17870, see Table 1 ), there were 77 + 55 miscarriages and 134 pregnancy terminations ( Table   1 ). The miscarriage rate in our total pregnant population can therefore be estimated to lie somewhere between 0.7% (77 + 55/ 17870) (95% CI 0.6 − 0.9) and 1.5% (77 + 55 + 134/17870) (95% CI 1.3−1.6). The highest figure should probably be slightly adjusted downwards, if we assume that some of the miscarriages among the women excluded were caused by amniocentesis or chorion villus sampling.
In our study population, the risk of miscarriage was not affected by gestational age or NT thickness, which are both 'generally accepted' risk factors for miscarriage. The absence of an association between NT thickness and miscarriage may be explained by no fetus in our study having NT >3mm; and the absence of an association between gestational age and miscarriage is likely to be explained by the narrow gestational age span at which the scans were performed (12 -14 weeks). Our results confirm those of others that in vitro fertilization does not seem to be a risk factor for miscarriage. 26, 27, 28 . The only risk factors were parity and previous spontaneous abortions, both being independent risk factors. Our finding that the risk of miscarriage increased with the number of previous miscarriages agrees with those of others 29, 30, 31 -34 , while parity has not previously been reported to be a risk factor for either first or second trimester miscarriage. Our results do not support that the association between parity and miscarriage risk was a result of bias, because the interaction between parity and number of previous miscarriages for participation in our study was not statistically significant, and parity was a highly significant risk factor for miscarriage even among women with no previous miscarriage. However, selection bias cannot be entirely excluded, because we have no information − and we have no possibility to obtain information retrospectively, our internet based database being anonymous − on previous stillbirths or preterm deliveries, which, theoretically, might be risk factors for miscarriage after 12 weeks 35, 36 , or on other possible risk factors, e.g., increased body mass index 37 , maternal smoking 38 , maternal diabetes 39 , anti-phospholipid syndrome 40 , or bleeding early in the current pregnancy 41 .
Therefore, we cannot determine if the presence of risk factors for miscarriage became more common with increasing parity because of unintended selection bias. If the latter were true, parity could simply be a confounder. We can only speculate about which mechanisms could explain a true association between parity and miscarriage. One possible mechanism is increasing ability with increasing parity to keep a fetus destined to die alive until the second trimester, another is unfavorable uterine environment for normal embryonic-fetal development in multipara. Uterine microcirculation/environment might change with each delivery so as to change the low-oxygen milieu necessary for normal embryonic development 42 .
Both we and others have found a U-shaped relationship between maternal age and risk of miscarriage 43, 44 . Possibly, the increased risk in the oldest women in our study is to be explained by the risk of fetal aneuploidy increasing with maternal age 45, 46 (and fetal aneuploidy being a common cause of miscarriage) despite most fetuses with major chromosomal anomalies almost certainly having been excluded from our study group. It is a weakness of our study that only a few fetuses lost in miscarriage underwent autopsy and karyotyping, a weakness that we probably share with most other studies reporting on miscarriage after a living fetus has been confirmed at a scan at 12 − 14 weeks 4, 5, 11, 13 . We can only make an approximate estimation of the true prevalence of fetal chromosomal anomalies in our study population. Among those women excluded who underwent fetal karyotyping because of pure worry, the prevalence of major chromosomal anomalies was 0.44% and that of clinically less important anomalies, e.g., Klinefelter's syndrome or balanced translocations, was 0.77% ( Figure 1 ). If we assume that these prevalences were the same in our study population (indeed, an unlikely assumption, because median risk of trisomy 21 in our study association between higher age and miscarriage could also be poorer health in older women, e.g., impaired function of the thyroid gland, which has been suggested to increase the risk of miscarriage 47 or uterine fibroids being more common in older women 48 and being a known risk factor for miscarriage 44 . The increased risk of miscarriage in the youngest women might be explained by specific obstetric risks among very young pregnant women. Women giving birth during their adolescence are at increased risk of adverse outcome both in terms of fetal loss 49, 50 and preterm birth 51 -53 . Whether the risk of fetal chromosomal anomalies is increased in very young women is debatable 54, 55 .
To sum up, in singleton pregnancies with an apparently normal fetus with estimated risk of Down's syndrome <1:250 according to NT screening at 12 -14 weeks, the spontaneous fetal loss rate before 25 weeks is likely to be around 0.5%. NT thickness up to 3 mm does not seem to affect the risk of miscarriage in such pregnancies, but the risk seems to increase with number of previous miscarriages and with parity, and possibly the risk is highest in the youngest and oldest mothers-to-be. ___________________________________________________________________________________________________________ * All estimates show the odds ratio for a one-step-increase, (e.g., if the OR for parity is 1.5, an increase in parity from 0 to 1 increases the odds of the outcome 1.5 times). † Bi-variate model including age and age CI, confidence interval *Maternal age was divided into classes as shown, the reference group being women 25 -29 years old. †The estimates show the odds ratios for a one-step -increase (e.g., if the OR for parity is 1.5, an increase in parity from 0 to 1 increases the odds of the outcome 1.5 times). Table 4 (´best´ model). Table 4 (the mathematical formula used to calculate the risk is available from the authors on request).
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